SFM
FBRX icon

Sphera Funds Management’s Forte Biosciences FBRX Stock Holding History

Sphera Funds Management’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.79M Sell
184,984
-885
-0.5% -$25.5K 0.76% 47
2025
Q4 		$5.07M Sell
185,869
-288,440
-61% -$5.06M 0.98% 43
2025
Q3 		$7.11M Sell
474,309
-20,800
-4% -$240K 1.5% 18
2025
Q2 		$6.4M Buy
+495,109
New +$4.26M 1.5% 19
2019
Q2 		– Sell
-320
Closed -$1.3M – 97
2019
Q1 		$1.3M Buy
+320
New +$1.24M 0.12% 89

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Sphera Funds Management's FBRX Position: Q1 2026 in Review

Sphera Funds Management reduced its Forte Biosciences (FBRX) stake by 0.48% in Q1 2026, selling an estimated $25.5K and leaving 184,984 shares worth $4.79M. The position accounts for 0.76% of the portfolio, ranked #47.

Sphera Funds Management first reported a position in FBRX in Q1 2019 and has held it in 5 quarters since. The position peaked at $7.11M in Q3 2025. 68 funds tracked by Wall St. Rank hold FBRX as of Q1 2026.

  • Sphera Funds Management held 184,984 shares of Forte Biosciences worth $4.79M as of Q1 2026.
  • Sphera Funds Management sold 885 Forte Biosciences shares in Q1 2026, an estimated $25.5K.
  • Forte Biosciences made up 0.76% of Sphera Funds Management's portfolio in Q1 2026, its #47 holding.
  • Sphera Funds Management first reported a position in Forte Biosciences in Q1 2019 and has held it in 5 quarters since.
  • Sphera Funds Management's Forte Biosciences position peaked at $7.11M in Q3 2025.
  • 68 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.